MSF calls on the stakeholders of the Global Fund to convene an emergency donor conference and to open a new early funding window to ensure that the Fund is fully functional in 2012.

More >

Learn how a free trade agreement between the European Union and India could restrict access to affordable medicines for millions of people with HIV/AIDS and other diseases and conditions.

More >

The crucial role India plays in supplying the developing world with affordable quality medicines is being threatened.

More >

In the past 5 years, considerable progress has been made in scaling-up access to antiretroviral therapy.  Today, 1.3 million people are receiving treatment.  But a huge amount remains to be done.

More >

Doctors Without Borders/Médecins Sans Frontières (MSF) is alarmed at the lack of availability of a key antiretroviral to treat HIV/AIDS, Gilead Science's tenofovir disoproxil fumarate (TDF), marketed as Viread®.

More >